SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.

Advertisement


Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

How Listing Ukraine As A Priority Foreign Country In Special 301 Violates WTO Agreements

Prof. Sean Flynn asks whether US sanctions of Ukraine under the US Special 301 program violates World Trade Organization rules. He also asks whether the operation of watch lists threatening sanctions for intellectual property matters could be challenged under the WTO even prior to any sanction going into effect.





Latest Comments
  • As it happens, I own and create "intellectual prop... »
  • So long term planning of the UN Development Decade... »

  • For IPW Subscribers
    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    Public Health

    26/02/2013: UN Agency Ties Fraudulent Pharmaceuticals To Organised Crime In West Africa
    26/02/2013: WIPO Patent Committee Moves Quickly Through Agenda; Heavy Lifting To Come
    18/02/2013: Monsanto, Myriad: Two US Legal Cases Shaking Biotech Industries
    13/02/2013: Event Explains Partnerships In Natural Products Research Through Thai Experience With Novartis
    13/02/2013: Texts Show Details Of EU Parliament Transparency Directive Vote
    12/02/2013: Letter Shows US Pressure On Global Fund For Compulsory Licensing, Generics
    11/02/2013: Report Proposes Solutions To Address Noncommunicable Diseases
    07/02/2013: People: Tracking IP Influencers’ Latest Moves
    06/02/2013: WHO, WTO, WIPO Provide Policymakers Policy Options For Public Health
    04/02/2013: Upcoming Law Summit To Address IP Management, Enforcement
    03/02/2013: Polio Talks At WHO Board: Between Progress Made, The Final Push And The Role Of Partnership
    31/01/2013: Inside Views: Pending Cutback In EU Spending For Development Cooperation
    30/01/2013: WHO Executive Board Concludes After ‘Unpredecented’ Workload
    29/01/2013: Inside Views: Potential Elements Of The WHO Global R&D Treaty: Tailoring Solutions For Disparate Contexts
    28/01/2013: WHO Board Approves Resolution On Neglected Diseases; Sets Action On Substandard Medicines
    28/01/2013: Debate Erupts At WHO Over “Consensus” On Financing R&D For The Poor
    28/01/2013: WHO Plan For Pandemic Flu Proceeds With Questions
    22/01/2013: UNITAID Seeks Bids For ‘Freedom To Operate’ IPR Analyses For HIV Products
    22/01/2013: 2013: India Battles For Right To Use Compulsory Licences To Make Medicines Affordable
    21/01/2013: Packed WHO Executive Board Agenda Highlights Need To Streamline Priorities
    18/01/2013: US FTC Finds Sharp Rise In ‘Pay-For-Delay’ Deals Blocking Generics
    18/01/2013: Official Offers Reflections On WHO Reform, Private Sector Role
    16/01/2013: Free Drugs Are “Crucial Part” Of Neglected Tropical Disease Fight
    09/01/2013: IP-Watch Looks At The Year Ahead In International IP Policy
    21/12/2012: US Supreme Court Poised To Rule Human Genes Are Not Patentable
    29/11/2012: WHO Members Agree On “Strategic Work Plan” On Health R&D – But No Convention
    29/11/2012: WHO Negotiations To Address Medical R&D Global Gaps Head Deep Into Night
    28/11/2012: International Instrument On Medical R&D Still On Negotiating Table At WHO
    27/11/2012: UNITAID: Alternative Funding Mechanism For AIDS Drugs Saving Lives
    27/11/2012: Special Report: With Poor And Uninsured A Majority, Southeast Asia Sees Rise In Generics
    25/11/2012: WHO Members Meet This Week To Address Global Gaps In Medical R&D
    22/11/2012: WHO Members Agree On Roadmap To Fight Poor Quality Medicines
    20/11/2012: WTO Dispute Body Hears Sides On Australia Tobacco Law
    19/11/2012: WHO Denies Industry Money Unduly Influencing Noncommunicable Disease Fight
    18/11/2012: Inside Views: Fixing Canada’s Access to Medicines Regime — Bill C-398
    15/11/2012: Global Fund Names Mark Dybul Executive Director
    14/11/2012: Recent Research Highlights Potential Of Open Access In Drug Discovery
    14/11/2012: Medicines Patent Pool Names New Director
    14/11/2012: Analysis: Argentine Court Clarifies What Patent Holders Can – And Cannot – Prohibit
    09/11/2012: Study Shows Drug Patents Can Be Extended For Decades
    09/11/2012: WHO Negotiations On Global Monitoring Framework Seen As Success In Noncommunicable Disease Fight
    09/11/2012: Inside Views: EU Health Cooperation — Room For Improvement
    09/11/2012: Technical Meeting Advances Ideas For WHO-Led R&D Financing Framework
    07/11/2012: WTO Members Launch Debate On IP And Innovation; LDCs Seek More Time To Enforce IP Rules
    05/11/2012: WTO TRIPS Council To Consider New Brazil-United States Item On Innovation
    04/11/2012: Landmark India IP Board Decision Against Hepatitis C Drug Patent
    01/11/2012: Pharma Outlook: Don’t Yield On IP, Work On Trust-Building, Call For Global Cooperation
    30/10/2012: WIPO-Sponsored Neglected Diseases Consortium Celebrates Successful First Year
    24/10/2012: Petition Urges Delay, Discussion Of Pan-African IP Organization
    23/10/2012: WHO Member States Hammering Out Details On Noncommunicable Diseases
    Your IP address is 54.234.126.92